The nature of Medicare-related litigation is varied, including, for example, problems with MSPA, Medicare Advantage programs, the rules governing the administration of skilled nursing medical services, and allegations of Medicare fraud in the form of the provision of medically unnecessary services.
U.S. v. Stricker
In United States of America v. Stricker, No. 09-CV-2423 (N.D. Ala. Sept. 30, 2010), the United States sued a number of parties, including insurers, who participated in a $300 million class action to resolve claims related to claims of exposure to polychlorinated biphenyl (PCB). The International Agency for Research on Cancer declared PCB to be a human carcinogen and the EPA declared it a probable carcinogen. It is generally agreed that many buildings and rivers have suffered contamination, and some organizations assert that food supplies have also been affected. The U.S. alleged that settlement proceeds were distributed without reimbursing Medicare for the medical care that it had provided to the settling class members. Medicare claimed that under the MSPA, insurers and others who participated in the settlement were liable to Medicare for up to double the amount of incurred medical expenses. The trial court dismissed the claim on the basis of the statute of limitations. The U.S. appealed to the U.S. Court of Appeals for the 11th Circuit, which affirmed the trial court’s ruling in United States of America v. Stricker, No. 11-14745, 524 Fed. Appx. 500 (11th Cir. July 26, 2013). The case is important for insurers involved in settlements with Medicare beneficiaries because it is one of the primary rulings to provide insight into Medicare’s recovery practices under the MSPA, especially as applied to mass torts and old class action settlements.
United States of America, ex rel. Benjamin Poehling v. UnitedHealth Group, Inc.
In United States of America, ex rel. Benjamin Poehling v. UnitedHealth Group, Inc., 11-cv-0258A, filed under seal in the Western District of New York in October 2011 and made public in February 2017, a whistleblower accused UnitedHealth Group and affiliated insurers of overcharging Medicare by possibly billions of dollars through their Medicare Advantage programs. The alleged overcharges were based on the insurer making people look sicker than they were by inflating patient risk scores, a practice known as “upcoding.” Mr. Poehling claimed that the insurer set “risk adjustment” targets for their employees, who were judged on whether they had sufficiently increased risk scores. Mr. Poehling alleged that coding specialists would examine patient records looking for long-term conditions that could be used to increase Medicare reimbursements. The Justice Department intervened in the pending case in 2017.
Jimmo v. Sebelius
In a 2013 settlement of Jimmo v. Sebelius, No. 11-cv-17 (D. Vt.), Medicare ended its longstanding policy that skilled medical services must be terminated unless a beneficiary with a chronic condition or disability can show a likelihood of improvement. This change benefitted those with chronic conditions like multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, ALS (Lou Gehrig’s disease), diabetes, hypertension, arthritis, heart disease and stroke. Under the changed policy, medical providers were required to treat patients with medically necessary nursing or therapy services in order to prevent or slow medical decline. The issue for insurers after Sebelius is whether the services are needed, not whether the patient will improve.
21st Century Oncology
21st Century Oncology’s Florida operation agreed to pay approximately $34.7 million in 2016 to settle allegations of Medicare fraud. The U.S. government claimed that Century Oncology performed a test that was intended to measure the exit dose radiating from a patient after radiation treatment, but that the procedure was medically unnecessary. The government also alleged that medical staff at 21st Century Oncology locations were not properly trained to interpret or use the test results.